Skip to content
Trial Eligibility
Menu

Vascular Disease Discovery Protocol

NCT03538639

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Background: Some genetic diseases put increase the risk of heart and blood diseases, which are the number one cause of death and disability in the U.S. Researchers want to study diseases of the heart and/or blood vessels. They want to collect data and specimens from affected people, their family members, and healthy people. Objective: To study diseases of the heart and/or blood vessels.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Vascular Dysfunction
  • Genetic Mutations
  • Genetic Predisposition

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
2 to 100 years
Sex
All
Healthy volunteers
Accepted
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Last updated on ClinicalTrials.gov
September 18, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Maryland · 1

  • National Institutes of Health Clinical Center · Bethesda, MD

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.